Providing market intelligence for more than 35 years

In The News

OTA-TV Climbing In U.S. Broadband Homes

Per the study, 81% of U.S. broadband homes still have a pay TV subscription, but only one-third of them are “very satisfied” with the service. Notably, 31% of U.S. broadband homes take multiple OTT service subscriptions, Parks Associates said.

Additionally, twice as many subs downgraded their pay TV service (12%) than upgraded it (6%) in 2016, and only half as many cord-nevers adopted pay TV in 2016 (2%) versus 2015 (4%).

“Pay-TV subscriptions have dropped each year since 2014, falling to 81% of U.S. broadband households in Q3 2016,” Brett Sappington, senior director of research at Parks Associates, said in a statement. “Several factors have played a part in this decline, including growth in the OTT video market, increasing costs for pay-TV services, and consumer awareness of available online alternatives.”

From the article "OTA-TV Climbing In U.S. Broadband Homes" by Jeff Baumgartner.

Previously In The News

Roku’s Share of Streaming Market Rising, Says Parks Report

As streaming becomes more popular as a way to consume TV programming, Roku is increasing the number of homes in which its devices are used, according to a new report from Parks Associates. In the f...

What Apple Can Learn From Its TV Failures

A new report from market-research firm Parks Associates places Apple fourth in terms of market share for streaming media players like the Apple TV, a sign that consumer infatuation with Apple products...

Apple plans 4K Apple TV to regain market share

Apple TV has lost streaming media market share while competitors thrive. A Parks Associates report this week showed Apple’s market share dropping from 19% in Q1 last year to 15% this year. Amazon’s Fi...

Apple (AAPL) and Hollywood Clash Over Pricing of 4K Content

Apple TV was launched in Jan 2007. It is a digital media player and HDMI compliant set top device that needs to be connected to TV to work. Apple TV also gives access to Apple's iTunes content as well...